Vaishali Pharma Limited has issued a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended December 31, 2025. The company confirmed that the said regulation is not applicable as all its shares are held in dematerialized form.

Furthermore, Vaishali Pharma has not received any requests from its members for rematerialization of shares during the aforementioned quarter. The certificate has been furnished to the stock exchange where the company's shares are listed. This compliance ensures adherence to SEBI regulations regarding share dematerialization and rematerialization processes.